Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc H Scheetz

Showing results (141-150 of 222) with videos related to

Pageof 23
Sort By:
Biorxiv : the Preprint Server for Biology|March 22, 2023
Iohexol-measured glomerular filtration rate and urinary biomarker changes between vancomycin and vancomycin plus piperacillin-tazobactam in a translational rat modelJack Chang, Gwendolyn M Pais, Sylwia Marianski, et al.
International Journal of Antimicrobial Agents|September 8, 2024
Past, present, and future biomarkers of kidney function and injury: The relationship with antibioticsJack Chang, Gwendolyn M Pais, Erin F Barreto, et al.
International Journal of Antimicrobial Agents|July 3, 2017
Population pharmacokinetics of cefepime in febrile neutropenia: implications for dose-dependent susceptibility and contemporary dosing regimensNathaniel J Rhodes, Meagan E Grove, Patrick J Kiel, et al.
Antimicrobial Agents and Chemotherapy|July 1, 2020
Population Pharmacokinetics and Target Attainment of Cefepime in Critically Ill Patients and Guidance for Initial DosingMohammad H Al-Shaer, Michael N Neely, Jiajun Liu, et al.
Pharmaceutics|April 30, 2021
Pharmacokinetic Disposition of Amiodarone When Given with an Intralipid Rescue StrategySean N Avedissian, Michelle Pham, Medha D Joshi, et al.
International Journal of Antimicrobial Agents|August 3, 2025
Piperacillin/tazobactam clearance predicted by non-creatinine based estimates of GFR in critically ill adultsErin F Barreto, Jack Chang, Andrew D Rule, et al.
Journal of Neuroscience Methods|April 28, 2023
A novel 4-cell in-vitro blood-brain barrier model and its characterization by confocal microscopy and TEER measurementJohid R Malik, Courtney V Fletcher, Anthony T Podany, et al.
Antimicrobial Agents and Chemotherapy|January 20, 2021
<i>In Vivo</i> Targeting of Escherichia coli with Vancomycin-ArginineLewis F Neville, Itamar Shalit, Peter A Warn, et al.
The Journal of Antimicrobial Chemotherapy|August 8, 2018
Measuring the impact of varying denominator definitions on standardized antibiotic consumption rates: implications for antimicrobial stewardship programmesSean N Avedissian, Marc H Scheetz, Teresa R Zembower, et al.
Critical Care Medicine|February 27, 2025
Cystatin C-Guided Dosing Nomogram Improves Target Attainment for Cefepime in the Critically IllErin F Barreto, Marc H Scheetz, Jack Chang, et al.
Pageof 23

Showing results (141-150 of 222) with videos related to

Sort By:
Pageof 23
Biorxiv : the Preprint Server for Biology|March 22, 2023
Iohexol-measured glomerular filtration rate and urinary biomarker changes between vancomycin and vancomycin plus piperacillin-tazobactam in a translational rat modelJack Chang, Gwendolyn M Pais, Sylwia Marianski, et al.
International Journal of Antimicrobial Agents|September 8, 2024
Past, present, and future biomarkers of kidney function and injury: The relationship with antibioticsJack Chang, Gwendolyn M Pais, Erin F Barreto, et al.
International Journal of Antimicrobial Agents|July 3, 2017
Population pharmacokinetics of cefepime in febrile neutropenia: implications for dose-dependent susceptibility and contemporary dosing regimensNathaniel J Rhodes, Meagan E Grove, Patrick J Kiel, et al.
Antimicrobial Agents and Chemotherapy|July 1, 2020
Population Pharmacokinetics and Target Attainment of Cefepime in Critically Ill Patients and Guidance for Initial DosingMohammad H Al-Shaer, Michael N Neely, Jiajun Liu, et al.
Pharmaceutics|April 30, 2021
Pharmacokinetic Disposition of Amiodarone When Given with an Intralipid Rescue StrategySean N Avedissian, Michelle Pham, Medha D Joshi, et al.
International Journal of Antimicrobial Agents|August 3, 2025
Piperacillin/tazobactam clearance predicted by non-creatinine based estimates of GFR in critically ill adultsErin F Barreto, Jack Chang, Andrew D Rule, et al.
Journal of Neuroscience Methods|April 28, 2023
A novel 4-cell in-vitro blood-brain barrier model and its characterization by confocal microscopy and TEER measurementJohid R Malik, Courtney V Fletcher, Anthony T Podany, et al.
Antimicrobial Agents and Chemotherapy|January 20, 2021
<i>In Vivo</i> Targeting of Escherichia coli with Vancomycin-ArginineLewis F Neville, Itamar Shalit, Peter A Warn, et al.
The Journal of Antimicrobial Chemotherapy|August 8, 2018
Measuring the impact of varying denominator definitions on standardized antibiotic consumption rates: implications for antimicrobial stewardship programmesSean N Avedissian, Marc H Scheetz, Teresa R Zembower, et al.
Critical Care Medicine|February 27, 2025
Cystatin C-Guided Dosing Nomogram Improves Target Attainment for Cefepime in the Critically IllErin F Barreto, Marc H Scheetz, Jack Chang, et al.
Pageof 23